<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01189292</url>
  </required_header>
  <id_info>
    <org_study_id>EKSG 10/082/2B</org_study_id>
    <nct_id>NCT01189292</nct_id>
  </id_info>
  <brief_title>Preoperative Single-dose Steroid Application for the Treatment of Nausea and Vomiting After Thyroid Surgery</brief_title>
  <acronym>tPONV</acronym>
  <official_title>Preoperative Single-dose Steroid Application for the Treatment of Nausea and Vomiting After Thyroid Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cantonal Hospital of St. Gallen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cantonal Hospital of St. Gallen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is to compare the postoperative recovery, as determined by postoperative nausea and
      vomiting (PONV) after preoperative application of single-dose dexamethasone versus saline in
      patients undergoing partial or total thyroidectomy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of Postoperative Nausea and Vomiting</measure>
    <time_frame>within 48 hours after surgery</time_frame>
    <description>Compare the postoperative recovery, as determined by postoperative nausea and vomiting (PONV) after preoperative application of single-dose dexamethasone versus saline in patients undergoing partial or total thyroidectomy (primary end-point)
any PONV event within 48 hours after surgery
PONV was measured at 4, 8, 16, 24, 32 and 48 hours after surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of Postoperative Nausea and Vomiting</measure>
    <time_frame>within 48 hours after surgery (PP)</time_frame>
    <description>Compare the postoperative recovery, as determined by postoperative nausea and vomiting (PONV) after preoperative application of single-dose dexamethasone versus saline in patients undergoing partial or total thyroidectomy (primary end-point)
any PONV event within 48 hours after surgery
PONV was measured at 4, 8, 16, 24, 32 and 48 hours after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of Post Operative Nausea and Vomiting</measure>
    <time_frame>4 hours after surgery</time_frame>
    <description>mild nausea:......single administration of an antiemetic drug
severe nausea: repeated administration of antiemetic drugs
vomiting:...........at least one vomiting event</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of Post Operative Nausea and Vomiting</measure>
    <time_frame>8 hours after surgery</time_frame>
    <description>mild nausea:......single administration of an antiemetic drug
severe nausea: repeated administration of antiemetic drugs
vomiting:...........at least one vomiting event</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Pain After Physical Stress</measure>
    <time_frame>4 and 8 hours after surgery</time_frame>
    <description>Compare grade of pain between the treatment (dexamethasone) and the control (saline) group
Pain was measured using a verbal rating scale ranging from 0 (no pain) to 10 in steps of 1
before obtaining the pain rating, patients were asked to turn their heads (physical stress)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Hospital Stay</measure>
    <time_frame>Difference between day of admission and day of discharge</time_frame>
    <description>Compare the lengths of hospital stay between the treatment (dexamethasone) and the control (saline) group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Necessary Anesthesiological Medication</measure>
    <time_frame>measured from beginning of anaesthesia to end of anaesthesia</time_frame>
    <description>Compare the amount of necessary anesthesiologic medication during the operation between the treatment (dexamethasone) and the control (saline) group</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">152</enrollment>
  <condition>Thyroidectomy</condition>
  <condition>Thyroid Diseases</condition>
  <arm_group>
    <arm_group_label>Dexamethasone injection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Administration of 8mg(2ml) intravenous Dexamethasone (Mephameson®)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo (NaCl 0.9%)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>8mg (2ml) of dexamethasone (Mephameson®) administered intravenously preoperatively before thyroid surgery</description>
    <arm_group_label>Dexamethasone injection</arm_group_label>
    <other_name>Mephameson</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>NaCl 0.9%</intervention_name>
    <description>2ml of NaCl 0.9% administered intravenously preoperatively before thyroid surgery</description>
    <arm_group_label>Placebo (NaCl 0.9%)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18

          -  Planned partial or total thyroidectomy

        Exclusion Criteria:

          -  History of adverse effects to dexamethasone or propyleneglycol or di-natrium-EDTA

          -  Patients with chronic pain

          -  Necessity for opioids-application in the postoperative course

          -  Not possible administration of a cervical block (0.5% bupivacaine at a dose of 20ml)

          -  Patients with Diabetes mellitus

          -  Pregnancy (test in young women)

          -  Glaucoma

          -  Patients who received antiemetic therapy within 48h before surgery

          -  Patients with acute pain requiring painkillers others than paracetamol or more than
             single dose NSAR treatment within 48h before surgery

          -  Use of psychotropic drugs

          -  Incompliant patients

          -  Preoperatively high suspicion of malignancy

          -  Re-operations
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Clerici, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cantonal Hospital St. Gallen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Surgery</name>
      <address>
        <city>St. Gallen</city>
        <zip>9007</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 19, 2010</study_first_submitted>
  <study_first_submitted_qc>August 25, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 26, 2010</study_first_posted>
  <results_first_submitted>February 26, 2015</results_first_submitted>
  <results_first_submitted_qc>June 29, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 7, 2015</results_first_posted>
  <last_update_submitted>June 29, 2015</last_update_submitted>
  <last_update_submitted_qc>June 29, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cantonal Hospital of St. Gallen</investigator_affiliation>
    <investigator_full_name>Ignazio Tarantino</investigator_full_name>
    <investigator_title>M.D:</investigator_title>
  </responsible_party>
  <keyword>postoperative nausea and vomitus</keyword>
  <keyword>PONV</keyword>
  <keyword>thyroid surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thyroid Diseases</mesh_term>
    <mesh_term>Nausea</mesh_term>
    <mesh_term>Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients older than 18 years scheduled for a primary partial or total thyroidectomy due to benign disease at the Kantonsspital St. Gallen, Department of Surgery were recruited.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Dexamethasone Injection</title>
          <description>Administration of 8mg(2ml) intravenous Dexamethasone (Mephameson®)
Dexamethasone: 8mg (2ml) of dexamethasone (Mephameson®) administered intravenously preoperatively before thyroid surgery</description>
        </group>
        <group group_id="P2">
          <title>Placebo (NaCl 0.9%)</title>
          <description>NaCl 0.9%: 2ml of NaCl 0.9% administered intravenously preoperatively before thyroid surgery</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Intention to Treat Analysis</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="76"/>
                <participants group_id="P2" count="76"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="76"/>
                <participants group_id="P2" count="76"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Per Protocol Analysis</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="76"/>
                <participants group_id="P2" count="76"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="65"/>
                <participants group_id="P2" count="60"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="16"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Dexamethasone Injection</title>
          <description>Administration of 8mg(2ml) intravenous Dexamethasone (Mephameson®)
Dexamethasone: 8mg (2ml) of dexamethasone (Mephameson®) administered intravenously preoperatively before thyroid surgery</description>
        </group>
        <group group_id="B2">
          <title>Placebo (NaCl 0.9%)</title>
          <description>NaCl 0.9%: 2ml of NaCl 0.9% administered intravenously preoperatively before thyroid surgery</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="76"/>
            <count group_id="B2" value="76"/>
            <count group_id="B3" value="152"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="70"/>
                    <measurement group_id="B2" value="67"/>
                    <measurement group_id="B3" value="137"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49.5" spread="12.0"/>
                    <measurement group_id="B2" value="48.4" spread="13.4"/>
                    <measurement group_id="B3" value="49.0" spread="12.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62"/>
                    <measurement group_id="B2" value="58"/>
                    <measurement group_id="B3" value="120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Switzerland</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="76"/>
                    <measurement group_id="B2" value="76"/>
                    <measurement group_id="B3" value="152"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body mass index</title>
          <units>kg/m²</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24.8" spread="4.1"/>
                    <measurement group_id="B2" value="25.4" spread="4.6"/>
                    <measurement group_id="B3" value="25.1" spread="4.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diagnosis</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Graves disease</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Goiter, multinodular</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Goiter, uninodular</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Type of surgery</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hemithyroidectomy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Near total thyroidectomy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total thyroidectomy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Lymph node dissection (C1/level VI)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>no</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63"/>
                    <measurement group_id="B2" value="65"/>
                    <measurement group_id="B3" value="128"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Operating time</title>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="126.2" spread="40.9"/>
                    <measurement group_id="B2" value="127.5" spread="45.7"/>
                    <measurement group_id="B3" value="126.8" spread="43.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Specimen weight</title>
          <units>gram</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45.3" spread="40.1"/>
                    <measurement group_id="B2" value="51.2" spread="58.2"/>
                    <measurement group_id="B3" value="48.3" spread="49.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Histology of specimen</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Papillary thyroid cancer (PTC)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Follicular thyroid cancer (FTC)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Benign disease</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69"/>
                    <measurement group_id="B2" value="67"/>
                    <measurement group_id="B3" value="136"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Incidence of Postoperative Nausea and Vomiting</title>
        <description>Compare the postoperative recovery, as determined by postoperative nausea and vomiting (PONV) after preoperative application of single-dose dexamethasone versus saline in patients undergoing partial or total thyroidectomy (primary end-point)
any PONV event within 48 hours after surgery
PONV was measured at 4, 8, 16, 24, 32 and 48 hours after surgery</description>
        <time_frame>within 48 hours after surgery</time_frame>
        <population>intention to treat analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone Injection</title>
            <description>Administration of 8mg(2ml) intravenous Dexamethasone (Mephameson®)
Dexamethasone: 8mg (2ml) of dexamethasone (Mephameson®) administered intravenously preoperatively before thyroid surgery</description>
          </group>
          <group group_id="O2">
            <title>Placebo (NaCl 0.9%)</title>
            <description>NaCl 0.9%: 2ml of NaCl 0.9% administered intravenously preoperatively before thyroid surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Postoperative Nausea and Vomiting</title>
          <description>Compare the postoperative recovery, as determined by postoperative nausea and vomiting (PONV) after preoperative application of single-dose dexamethasone versus saline in patients undergoing partial or total thyroidectomy (primary end-point)
any PONV event within 48 hours after surgery
PONV was measured at 4, 8, 16, 24, 32 and 48 hours after surgery</description>
          <population>intention to treat analysis</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="76"/>
                <count group_id="O2" value="76"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29" lower_limit="20" upper_limit="40"/>
                    <measurement group_id="O2" value="57" lower_limit="45" upper_limit="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>null hypothesis: Incidence of PONV is the same in both treatment arms</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>28</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>12</ci_lower_limit>
            <ci_upper_limit>42</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Incidence of Postoperative Nausea and Vomiting</title>
        <description>Compare the postoperative recovery, as determined by postoperative nausea and vomiting (PONV) after preoperative application of single-dose dexamethasone versus saline in patients undergoing partial or total thyroidectomy (primary end-point)
any PONV event within 48 hours after surgery
PONV was measured at 4, 8, 16, 24, 32 and 48 hours after surgery</description>
        <time_frame>within 48 hours after surgery (PP)</time_frame>
        <population>per protocol analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone Injection</title>
            <description>Administration of 8mg(2ml) intravenous Dexamethasone (Mephameson®)
Dexamethasone: 8mg (2ml) of dexamethasone (Mephameson®) administered intravenously preoperatively before thyroid surgery</description>
          </group>
          <group group_id="O2">
            <title>Placebo (NaCl 0.9%)</title>
            <description>NaCl 0.9%: 2ml of NaCl 0.9% administered intravenously preoperatively before thyroid surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Postoperative Nausea and Vomiting</title>
          <description>Compare the postoperative recovery, as determined by postoperative nausea and vomiting (PONV) after preoperative application of single-dose dexamethasone versus saline in patients undergoing partial or total thyroidectomy (primary end-point)
any PONV event within 48 hours after surgery
PONV was measured at 4, 8, 16, 24, 32 and 48 hours after surgery</description>
          <population>per protocol analysis</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="65"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28" lower_limit="18" upper_limit="40"/>
                    <measurement group_id="O2" value="52" lower_limit="39" upper_limit="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>per protocol analysis</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.006</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>24</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>7</ci_lower_limit>
            <ci_upper_limit>40</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Degree of Post Operative Nausea and Vomiting</title>
        <description>mild nausea:......single administration of an antiemetic drug
severe nausea: repeated administration of antiemetic drugs
vomiting:...........at least one vomiting event</description>
        <time_frame>4 hours after surgery</time_frame>
        <population>intention to treat</population>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone Injection</title>
            <description>Administration of 8mg(2ml) intravenous Dexamethasone (Mephameson®)
Dexamethasone: 8mg (2ml) of dexamethasone (Mephameson®) administered intravenously preoperatively before thyroid surgery</description>
          </group>
          <group group_id="O2">
            <title>Placebo (NaCl 0.9%)</title>
            <description>NaCl 0.9%: 2ml of NaCl 0.9% administered intravenously preoperatively before thyroid surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Degree of Post Operative Nausea and Vomiting</title>
          <description>mild nausea:......single administration of an antiemetic drug
severe nausea: repeated administration of antiemetic drugs
vomiting:...........at least one vomiting event</description>
          <population>intention to treat</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="76"/>
                <count group_id="O2" value="76"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>mild nausea</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>severe nausea</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>vomiting</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Degree of Post Operative Nausea and Vomiting</title>
        <description>mild nausea:......single administration of an antiemetic drug
severe nausea: repeated administration of antiemetic drugs
vomiting:...........at least one vomiting event</description>
        <time_frame>8 hours after surgery</time_frame>
        <population>intention to treat</population>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone Injection</title>
            <description>Administration of 8mg(2ml) intravenous Dexamethasone (Mephameson®)
Dexamethasone: 8mg (2ml) of dexamethasone (Mephameson®) administered intravenously preoperatively before thyroid surgery</description>
          </group>
          <group group_id="O2">
            <title>Placebo (NaCl 0.9%)</title>
            <description>NaCl 0.9%: 2ml of NaCl 0.9% administered intravenously preoperatively before thyroid surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Degree of Post Operative Nausea and Vomiting</title>
          <description>mild nausea:......single administration of an antiemetic drug
severe nausea: repeated administration of antiemetic drugs
vomiting:...........at least one vomiting event</description>
          <population>intention to treat</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="76"/>
                <count group_id="O2" value="76"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>mild nausea</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>severe nausea</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>vomiting</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Postoperative Pain After Physical Stress</title>
        <description>Compare grade of pain between the treatment (dexamethasone) and the control (saline) group
Pain was measured using a verbal rating scale ranging from 0 (no pain) to 10 in steps of 1
before obtaining the pain rating, patients were asked to turn their heads (physical stress)</description>
        <time_frame>4 and 8 hours after surgery</time_frame>
        <population>intention to treat analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone Injection</title>
            <description>Administration of 8mg(2ml) intravenous Dexamethasone (Mephameson®)
Dexamethasone: 8mg (2ml) of dexamethasone (Mephameson®) administered intravenously preoperatively before thyroid surgery</description>
          </group>
          <group group_id="O2">
            <title>Placebo (NaCl 0.9%)</title>
            <description>NaCl 0.9%: 2ml of NaCl 0.9% administered intravenously preoperatively before thyroid surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Pain After Physical Stress</title>
          <description>Compare grade of pain between the treatment (dexamethasone) and the control (saline) group
Pain was measured using a verbal rating scale ranging from 0 (no pain) to 10 in steps of 1
before obtaining the pain rating, patients were asked to turn their heads (physical stress)</description>
          <population>intention to treat analysis</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="76"/>
                <count group_id="O2" value="76"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>4 hours after surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.88" spread="1.52"/>
                    <measurement group_id="O2" value="2.09" spread="1.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hours after surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.88" spread="1.54"/>
                    <measurement group_id="O2" value="2.01" spread="1.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.674</p_value>
            <method>Mixed Models Analysis</method>
            <method_desc>mixed model over the mean ranks at all time points measured (4, 8, 16, 24, 32, 48 hours)</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Hospital Stay</title>
        <description>Compare the lengths of hospital stay between the treatment (dexamethasone) and the control (saline) group</description>
        <time_frame>Difference between day of admission and day of discharge</time_frame>
        <population>intention to treat</population>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone Injection</title>
            <description>Administration of 8mg(2ml) intravenous Dexamethasone (Mephameson®)
Dexamethasone: 8mg (2ml) of dexamethasone (Mephameson®) administered intravenously preoperatively before thyroid surgery</description>
          </group>
          <group group_id="O2">
            <title>Placebo (NaCl 0.9%)</title>
            <description>NaCl 0.9%: 2ml of NaCl 0.9% administered intravenously preoperatively before thyroid surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Hospital Stay</title>
          <description>Compare the lengths of hospital stay between the treatment (dexamethasone) and the control (saline) group</description>
          <population>intention to treat</population>
          <units>hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="76"/>
                <count group_id="O2" value="76"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.3" spread="15.7"/>
                    <measurement group_id="O2" value="48.1" spread="12.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.835</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Necessary Anesthesiological Medication</title>
        <description>Compare the amount of necessary anesthesiologic medication during the operation between the treatment (dexamethasone) and the control (saline) group</description>
        <time_frame>measured from beginning of anaesthesia to end of anaesthesia</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone Injection</title>
            <description>Administration of 8mg(2ml) intravenous Dexamethasone (Mephameson®)
Dexamethasone: 8mg (2ml) of dexamethasone (Mephameson®) administered intravenously preoperatively before thyroid surgery</description>
          </group>
          <group group_id="O2">
            <title>Placebo (NaCl 0.9%)</title>
            <description>NaCl 0.9%: 2ml of NaCl 0.9% administered intravenously preoperatively before thyroid surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Necessary Anesthesiological Medication</title>
          <description>Compare the amount of necessary anesthesiologic medication during the operation between the treatment (dexamethasone) and the control (saline) group</description>
          <units>milligram</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="76"/>
                <count group_id="O2" value="76"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Propofol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1097" spread="422"/>
                    <measurement group_id="O2" value="1168" spread="422"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remifentanil</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.944" spread="1.197"/>
                    <measurement group_id="O2" value="1.978" spread="1.111"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fentanyl</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.427" spread="0.111"/>
                    <measurement group_id="O2" value="0.444" spread="0.108"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Rocuronium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.7" spread="7.3"/>
                    <measurement group_id="O2" value="39.7" spread="8.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>during hospitalisation (on average 2 days)</time_frame>
      <desc>adverse events were recorded during the hospital stay</desc>
      <group_list>
        <group group_id="E1">
          <title>Dexamethasone Injection</title>
          <description>Administration of 8mg(2ml) intravenous Dexamethasone (Mephameson®)
Dexamethasone: 8mg (2ml) of dexamethasone (Mephameson®) administered intravenously preoperatively before thyroid surgery</description>
        </group>
        <group group_id="E2">
          <title>Placebo (NaCl 0.9%)</title>
          <description>NaCl 0.9%: 2ml of NaCl 0.9% administered intravenously preoperatively before thyroid surgery</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="76"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>Clavien Dindo</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="76"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="76"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>temporary hypoparathyroidism</sub_title>
                <description>Grade 2 on Clavien-Dindo scale</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="76"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="76"/>
              </event>
              <event>
                <sub_title>hypocalcemia</sub_title>
                <description>CTCAE grade 2</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="76"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title vocab="CTCAE">medical adverse events grade 1</sub_title>
                <description>for example: coughing, sinus tachycardia, temporary compensated renal insufficiency</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="76"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="76"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Allergic reaction to metamizole</sub_title>
                <description>CTCAE grade 2</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="76"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>surgical adverse event grade I</sub_title>
                <description>for example: recurrent laryngeal nerve palsy, hoarseness, minor bleeding</description>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="76"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="76"/>
              </event>
              <event>
                <sub_title>bleeding requiring reoperation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="76"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="76"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>all patients received a bilateral superficial cervical plexus block during surgery which could explain the very low postoperative pain scores compared to other similar studies</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Ignazio Tarantino</name_or_title>
      <organization>Department of General, Abdominal and Transplant Surgery, University of Heidelberg</organization>
      <email>ignazio.tarantino@med.uni-heidelberg.de</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

